Articles Tagged With:
-
The MRC/EORTC Neoadjuvant Chemotherapy Trial for Advanced Bladder Cancer
-
An Inhibitor of p53 as a Normal Tissue Protector Against Cancer Therapy
-
Full October 1999 Issue in PDF
-
Attendance expected to rise for NAHC’s annual meeting in SD
-
HCFA suspends new advance beneficiary notice requirement
-
Briefly Noted
-
Congress struggles to find a remedy for BBA woes
-
Star Multi Care looking to return to profitability by restructuring
-
New JCAHO compliance guidebook is available
-
Companies in the News